Niki BioSolutions, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Niki BioSolutions, Inc. (NIKI) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $2.68 per share for the 6-month period ending 2023-06-30, per its 6-K filed 2024-12-20.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2024-12-20
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month as first filed | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|
| 2023-06-30 | $2.68 6-K · filed 2024-12-20 | |||
| 2022-12-31 | $13.40 20-F · filed 2023-04-28 | |||
| 2022-06-30 | $13.40 6-K · filed 2023-12-22 | $1.34 6-K · filed 2022-09-30 | ||
| 2021-12-31 | $27.60 20-F · filed 2023-04-28 | $2.76 20-F · filed 2022-04-29 | ||
| 2021-06-30 | $2.76 6-K · filed 2022-09-30 | |||
| 2020-12-31 | $30.40 20-F · filed 2023-04-28 | $3.04 20-F · filed 2021-04-19 | ||
| 2020-06-30 | $3.02 6-K · filed 2021-09-15 | |||
| 2019-12-31 | $12.91 20-F/A · filed 2023-01-17 |